Oncimmune Holdings full year results and conference call

DirectorsTalk Interviews

Oncimmune Holdings plc (LON:ONC), the leading global immunodiagnostics group, states that it will be announcing its full year results for the year ended 31st May 2020 on Friday, 30 October 2020.

Adam Hill, Chief Executive Officer, together with Matthew Hall, Chief Financial Officer, will host a presentation and conference call for analysts at 11:30am GMT on the day of the results.

For conference call details please contact Alexander Davis of FTI Consulting at Alexander.Davis@fticonsulting.com or 020 3727 1000.

The management team will also host on Investor Meet Company a live presentation of the results on Friday, 30 October at 15:00 GMT.

• The online presentation will be open to all existing shareholders and potential new investors.

• Questions can be submitted before the event via your Investor Meet Company dashboard or at any time during the live presentation via the “Ask a Question” function. Responses to the Q&A will be published at the earliest opportunity on the Investor Meet Company platform.

• Investor feedback can also be submitted directly to management immediately following the event.

Access to Investor Meet Company is free and interested parties can register to attend the presentation via the following link: https://www.investormeetcompany.com/essensys-plc/register-investor

Attendees who have already registered on the Investor Meet Company platform to meet the Oncimmune Holdings will automatically receive an invitation to the presentation.

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:

Latest Company News

Ilika plc Advances Solid-State Batteries With 10Ah Goliath Breakthrough (Video)

Ilika plc has shipped its 10Ah Goliath solid-state battery prototypes, marking a major scale-up from earlier designs. CEO Graeme Purdy outlines how higher-energy materials and an automated pilot line delivered a 93% yield, signalling readiness for larger-scale manufacturing.

Harbour Energy to acquire Waldorf subsidiaries in $170m deal, boosting UK production

Harbour Energy has agreed to acquire most subsidiaries of Waldorf Energy Partners and Waldorf Production for $170 million, a move expected to add 20 kboepd of oil weighted production and 35 mmboe of 2P reserves.

TwentyFour Income Fund reports positive month as ABS and CLO issuance hits post-crisis highs

TwentyFour Income Fund noted improved market sentiment in November, supported by progress in Ukraine peace discussions and a stable UK Budget response.

GSK RSV vaccine recommended for wider adult use, CHMP backs expansion

GSK has announced that the EMA’s CHMP has recommended broadening the indication of its adjuvanted RSV vaccine to adults aged 18 and over, with a final decision expected in February 2026.

UK equities regain investor interest as valuation opportunities widen

Fidelity Special Values manager Alex Wright says UK equities have seen renewed interest as valuations remain attractive compared with global peers. The trust continues to follow a contrarian approach, focusing on undervalued mid and small cap companies and aiming to identify positive change not yet reflected in share prices.

Global Opportunities Trust reaffirms successful value and absolute-return strategy (LON: GOT)

As at the end of October 2025, Global Opportunities Trust continued to apply its value focused strategy across global markets, holding a blend of equities, private market investments and significant liquidity positions.

    Search

    Search